The general practitioner's use and expectations of an accident and emergency department We would like to comment on some of the recommendations made in the article by Morrison et al. (April 1990 JRSM, P 237).
(1) 70% were interested in attending joint meetings: We have run a large annual course which started in 1980 as a joint meeting with delegates from various A & E departments and general practice. Over the next seven years the number of A & E doctors from outside the district dropped, but general practitioners continued to attend in large numbers. At our last meeting on 29 March 1990, 147 general practitioners attended and the vast majority found it very useful. A & E administrative staff mingle with delegates during tea and dinner breaks to listen to problems GPs encounter with the hospital.
(2) Communication: The A & E department sends out a quarterly newsletter to general practitioners to keep them abreast of new developments. It points out in a non-judgmental manner problems experienced by the department in receiving emergencies initially managed by GPs. The newsletter also invites comment from its recipients. This has worked well over the years.
This department has a real-time computer system with facilities for free text that produces a letter to the general practitioner for each patient attendance. This is not a perfect system because some of the younger general practitioners prefer the recently discarded system of receiving the top copy of a triple NCR record card. field is progressing at a rapid pace and it is, therefore, quite possible that the non-specialist may be completely unaware of the literature in this important area. The effects ofNSAIDs on the terminal ileum range from an early increase in mucosal 'leakiness' (or permeability) to changes in bile acid malabsorption, ulceration, bleeding and, less commonly, strictures and perforation. Increases in colonic permeability and ulceration are also recognized-A Some of these changes appear to be protected against by misoprostil" and ingestion of mixtures of glucose/ citrate", This fascinating condition is not merely important in its own right, but affords many similarities with inflammatory bowel disease in man", We have validated an experimental animal model of the condition", and used it to study both the mechanisms of action of various therapeutic agents? and also to study the pathophysiological sequence of events leading both to the increase in permeability and morphological sequelae. We are currently completing studies that indicate changes in eicosanoid levels, tissue nucleotide and mitochondrial metabolite handling, and free radical production and damage may be crucial in early NSAID enteropathy and, therefore, in inflammatory bowel diseases.
The clinician should, therefore, be aware of the protean effects of NSAIDs on the small gut, the potentially high incidence of side effects and, finally, that strategies are being actively sought to rationalise the pathogenesis and treatment of both NSAID enteropathy and inflammatory bowel diseases in generals:". ANJAN 
